-
1
-
-
84858193763
-
Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity
-
Ahmed F, Urooj A, (2012). Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity. Pharm Biol 50: 468-473.
-
(2012)
Pharm Biol
, vol.50
, pp. 468-473
-
-
Ahmed, F.1
Urooj, A.2
-
2
-
-
84890472386
-
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1797-1867
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
3
-
-
66449103252
-
Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin
-
Bains OS, Karkling MJ, Grigliatti TA, Reid RE, Riggs KW, (2009). Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. Drug Metab Dispos 37: 1107-1114.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 1107-1114
-
-
Bains, O.S.1
Karkling, M.J.2
Grigliatti, T.A.3
Reid, R.E.4
Riggs, K.W.5
-
4
-
-
78649613721
-
Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin
-
Bains OS, Grigliatti TA, Reid RE, Riggs KW, (2010). Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. J Pharmacol Exp Ther 335: 533-545.
-
(2010)
J Pharmacol Exp Ther
, vol.335
, pp. 533-545
-
-
Bains, O.S.1
Grigliatti, T.A.2
Reid, R.E.3
Riggs, K.W.4
-
5
-
-
46049104446
-
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinine oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
-
Blanco JG, Leisenring WM, Gonzalez-Covarrubias VM, Kawashima TI, Davies SM, Relling MV, et al. (2008). Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinine oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 112: 2789-2795.
-
(2008)
Cancer
, vol.112
, pp. 2789-2795
-
-
Blanco, J.G.1
Leisenring, W.M.2
Gonzalez-Covarrubias, V.M.3
Kawashima, T.I.4
Davies, S.M.5
Relling, M.V.6
-
7
-
-
84858192412
-
Protective effects of silymarin against doxorubicin-induced toxicity
-
Cecen E, Dost T, Culhaci N, Karul A, Ergur B, Birincioglu M, (2011). Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pac J Cancer Prev 12: 2697-2704.
-
(2011)
Asian Pac J Cancer Prev
, vol.12
, pp. 2697-2704
-
-
Cecen, E.1
Dost, T.2
Culhaci, N.3
Karul, A.4
Ergur, B.5
Birincioglu, M.6
-
8
-
-
59349113924
-
Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis
-
El-Hawari Y1, Favia AD, Pilka ES, Kisiela M, Oppermann U, Martin HJ, et al. (2009). Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis. Chem Biol Interact 178: 234-241.
-
(2009)
Chem Biol Interact
, vol.178
, pp. 234-241
-
-
El-Hawari, Y.1
Favia, A.D.2
Pilka, E.S.3
Kisiela, M.4
Oppermann, U.5
Martin, H.J.6
-
10
-
-
0034665414
-
Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice
-
Forrest GL, Gonzalez B, Tseng W, Li X, Mann J, (2002). Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice. Cancer Res 60: 5158-5164.
-
(2002)
Cancer Res
, vol.60
, pp. 5158-5164
-
-
Forrest, G.L.1
Gonzalez, B.2
Tseng, W.3
Li, X.4
Mann, J.5
-
11
-
-
44749085662
-
Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)
-
Gonzalez-Covarrubias V1, Kalabus JL, Blanco JG, (2008). Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER). Pharm Res 25: 1730-1734.
-
(2008)
Pharm Res
, vol.25
, pp. 1730-1734
-
-
Gonzalez-Covarrubias, V.1
Kalabus, J.L.2
Blanco, J.G.3
-
12
-
-
84898809667
-
Insights into drug discovery from natural medicines using reverse pharmacokinetics
-
Hao H, Zheng X, Wang G, (2014). Insights into drug discovery from natural medicines using reverse pharmacokinetics. Trends Pharmacol Sci 35: 168-177.
-
(2014)
Trends Pharmacol Sci
, vol.35
, pp. 168-177
-
-
Hao, H.1
Zheng, X.2
Wang, G.3
-
13
-
-
0029796045
-
The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells
-
Hasinoff BB, Yalowich JC, Ling Y, Buss JL, (1996). The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells. Anticancer Drugs 7: 558-567.
-
(1996)
Anticancer Drugs
, vol.7
, pp. 558-567
-
-
Hasinoff, B.B.1
Yalowich, J.C.2
Ling, Y.3
Buss, J.L.4
-
14
-
-
0033025348
-
The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis
-
Hasinoff BB, Chee GL, Thampatty P, Allan WP, Yalowich JC, (1999). The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis. Anticancer Drugs 10: 47-54.
-
(1999)
Anticancer Drugs
, vol.10
, pp. 47-54
-
-
Hasinoff, B.B.1
Chee, G.L.2
Thampatty, P.3
Allan, W.P.4
Yalowich, J.C.5
-
15
-
-
0037159593
-
23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells
-
Ji ZN, Ye WC, Liu GG, Hsiao W, (2002). 23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells. Life Sci 72: 1-9.
-
(2002)
Life Sci
, vol.72
, pp. 1-9
-
-
Ji, Z.N.1
Ye, W.C.2
Liu, G.G.3
Hsiao, W.4
-
16
-
-
80051646543
-
Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy
-
Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, et al. (2011). Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation 8: 100.
-
(2011)
J Neuroinflammation
, vol.8
, pp. 100
-
-
Kang, A.1
Hao, H.2
Zheng, X.3
Liang, Y.4
Xie, Y.5
Xie, T.6
-
17
-
-
52949118777
-
Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver
-
Kassner N, Huse K, Martin HJ, Gödtel-Armbrust U, Metzger A, Meineke I, et al. (2008). Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab Dispos 36: 2113-2120.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 2113-2120
-
-
Kassner, N.1
Huse, K.2
Martin, H.J.3
Gödtel-Armbrust, U.4
Metzger, A.5
Meineke, I.6
-
18
-
-
77954326944
-
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
-
Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1577-1579
-
-
Kilkenny, C.1
Browne, W.2
Cuthill, I.C.3
Emerson, M.4
Altman, D.G.5
-
19
-
-
77950815766
-
Pharmacogenetics of target genes across doxorubicin disposition pathway: A review
-
Lal S, Mahajan A, Chen WN, Chowbay B, (2010). Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. Curr Drug Metab 11: 115-128.
-
(2010)
Curr Drug Metab
, vol.11
, pp. 115-128
-
-
Lal, S.1
Mahajan, A.2
Chen, W.N.3
Chowbay, B.4
-
20
-
-
77954331629
-
Guidelines for reporting experiments involving animals: The ARRIVE guidelines
-
McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
-
(2010)
Br J Pharmacol
, vol.160
, pp. 1573-1576
-
-
McGrath, J.1
Drummond, G.2
McLachlan, E.3
Kilkenny, C.4
Wainwright, C.5
-
21
-
-
34548301536
-
An introduction to the metabolic determinants of anthracycline cardiotoxicity
-
Menna P, Recalcati S, Cairo G, Minotti G, (2007). An introduction to the metabolic determinants of anthracycline cardiotoxicity. Cardiovasc Toxicol 7: 80-85.
-
(2007)
Cardiovasc Toxicol
, vol.7
, pp. 80-85
-
-
Menna, P.1
Recalcati, S.2
Cairo, G.3
Minotti, G.4
-
22
-
-
70350787143
-
Aldo-keto reductase (AKR) superfamily: Genomics and annotation
-
Mindnich RD, Penning TM, (2009). Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum Genomics 3: 362-370.
-
(2009)
Hum Genomics
, vol.3
, pp. 362-370
-
-
Mindnich, R.D.1
Penning, T.M.2
-
23
-
-
0035576817
-
Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: Evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy
-
Minotti G, Ronchi R, Salvatorelli E, Menna P, Cairo G, (2001). Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res 61: 8422-8488.
-
(2001)
Cancer Res
, vol.61
, pp. 8422-8488
-
-
Minotti, G.1
Ronchi, R.2
Salvatorelli, E.3
Menna, P.4
Cairo, G.5
-
24
-
-
0041694227
-
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: Biochemical aspects and pharmacologic implications
-
Mordente A, Minotti G, Martorana GE, Silvestrini A, Giardina B, Meucci E, (2003). Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications. Biochem Pharmacol 66: 989-998.
-
(2003)
Biochem Pharmacol
, vol.66
, pp. 989-998
-
-
Mordente, A.1
Minotti, G.2
Martorana, G.E.3
Silvestrini, A.4
Giardina, B.5
Meucci, E.6
-
25
-
-
0242321133
-
Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1
-
Olson LE, Bedja D, Alvey SJ, Cardounel AJ, Gabrielson KL, Reeves RH, (2003). Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res 63: 6602-6606.
-
(2003)
Cancer Res
, vol.63
, pp. 6602-6606
-
-
Olson, L.E.1
Bedja, D.2
Alvey, S.J.3
Cardounel, A.J.4
Gabrielson, K.L.5
Reeves, R.H.6
-
26
-
-
84891791940
-
The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
-
NC-IUPHAR. (Database Issue)
-
Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-1106.
-
(2014)
Nucl Acids Res
, vol.42
, pp. D1098-D1106
-
-
Pawson, A.J.1
Sharman, J.L.2
Benson, H.E.3
Faccenda, E.4
Alexander, S.P.5
Buneman, O.P.6
-
27
-
-
79955655749
-
Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer
-
Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. (2010). Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 4: 297-307.
-
(2010)
Biosci Trends
, vol.4
, pp. 297-307
-
-
Qi, F.1
Li, A.2
Inagaki, Y.3
Gao, J.4
Li, J.5
Kokudo, N.6
-
28
-
-
84859953907
-
Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin
-
Salvatorelli E, Menna P, Gonzalez Paz O, Surapaneni S, Aukerman SL, Chello M, et al. (2012). Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin. J Pharmacol Exp Ther 341: 474-483.
-
(2012)
J Pharmacol Exp Ther
, vol.341
, pp. 474-483
-
-
Salvatorelli, E.1
Menna, P.2
Gonzalez Paz, O.3
Surapaneni, S.4
Aukerman, S.L.5
Chello, M.6
-
29
-
-
84873836880
-
Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection
-
Stěrba M, Popelová O, Vávrová A, Jirkovský E, Kovaříková P, Geršl V, et al. (2013). Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal 18: 899-929.
-
(2013)
Antioxid Redox Signal
, vol.18
, pp. 899-929
-
-
Stěrba, M.1
Popelová, O.2
Vávrová, A.3
Jirkovský, E.4
Kovaříková, P.5
Geršl, V.6
-
30
-
-
33847096349
-
Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management
-
Takemura G, Fujiwara H, (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49: 330-352.
-
(2007)
Prog Cardiovasc Dis
, vol.49
, pp. 330-352
-
-
Takemura, G.1
Fujiwara, H.2
-
31
-
-
84876796922
-
Transthoracic echocardiography reference values in juvenile and adult 129/Sv mice
-
Vinhas M, Araújo AC, Ribeiro S, Rosário LB, Belo JA, (2013). Transthoracic echocardiography reference values in juvenile and adult 129/Sv mice. Cardiovasc Ultrasound 11: 12. doi: 10.1186/1476-7120-11-12.
-
(2013)
Cardiovasc Ultrasound
, vol.11
, pp. 12
-
-
Vinhas, M.1
Araújo, A.C.2
Ribeiro, S.3
Rosário, L.B.4
Belo, J.A.5
-
32
-
-
33646002630
-
Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models
-
Xie X, Eberding A, Madera C, Fazli L, Jia W, Goldenberg L, et al. (2006). Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J Urol 175: 1926-1931.
-
(2006)
J Urol
, vol.175
, pp. 1926-1931
-
-
Xie, X.1
Eberding, A.2
Madera, C.3
Fazli, L.4
Jia, W.5
Goldenberg, L.6
-
33
-
-
84868538356
-
BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo
-
Zhang DM, Shu C, Chen JJ, Sodani K, Wang J, Bhatnagar J, et al. (2012a). BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo. Mol Pharm 9: 3147-3159.
-
(2012)
Mol Pharm
, vol.9
, pp. 3147-3159
-
-
Zhang, D.M.1
Shu, C.2
Chen, J.J.3
Sodani, K.4
Wang, J.5
Bhatnagar, J.6
-
34
-
-
78649580065
-
20(S)-ginsenoside rh2 noncompetitively inhibits p-glycoprotein in vitro and in vivo: A case for herb-drug interactions
-
Zhang J, Zhou F, Wu X, Gu Y, Ai H, Zheng Y, et al. (2010). 20(S)-ginsenoside rh2 noncompetitively inhibits p-glycoprotein in vitro and in vivo: a case for herb-drug interactions. Drug Metab Dispos 38: 2179-2187.
-
(2010)
Drug Metab Dispos
, vol.38
, pp. 2179-2187
-
-
Zhang, J.1
Zhou, F.2
Wu, X.3
Gu, Y.4
Ai, H.5
Zheng, Y.6
-
35
-
-
82955184560
-
Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells
-
Zhang J, Zhou F, Wu X, Zhang X, Chen Y, Zha BS, et al. (2012b). Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Br J Pharmacol 165: 120-134.
-
(2012)
Br J Pharmacol
, vol.165
, pp. 120-134
-
-
Zhang, J.1
Zhou, F.2
Wu, X.3
Zhang, X.4
Chen, Y.5
Zha, B.S.6
-
36
-
-
77951206515
-
23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo
-
Zheng Y, Zhou F, Wu X, Wen X, Li Y, Yan B, et al. (2010). 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. J Ethnopharmacol 128: 615-622.
-
(2010)
J Ethnopharmacol
, vol.128
, pp. 615-622
-
-
Zheng, Y.1
Zhou, F.2
Wu, X.3
Wen, X.4
Li, Y.5
Yan, B.6
-
37
-
-
34848914074
-
Synthesis and antitumor activity of derivatives of 23-hydroxybetulinic acid
-
Zhou JP, Li D, Wu XM, Ye WC, Zhang LY, (2007). Synthesis and antitumor activity of derivatives of 23-hydroxybetulinic acid. Chin Chem Lett 18: 1195-1198.
-
(2007)
Chin Chem Lett
, vol.18
, pp. 1195-1198
-
-
Zhou, J.P.1
Li, D.2
Wu, X.M.3
Ye, W.C.4
Zhang, L.Y.5
-
38
-
-
0037274873
-
Cardiac toxicity of antineoplastic anthracyclines
-
Zucchi R, Danesi R, (2003). Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 3: 151-171.
-
(2003)
Curr Med Chem Anticancer Agents
, vol.3
, pp. 151-171
-
-
Zucchi, R.1
Danesi, R.2
|